Literature DB >> 19536584

Reduced levodopa-induced complications after 5 years of subthalamic stimulation in Parkinson's disease: a second honeymoon.

Clemence Simonin1, M Tir, D Devos, A Kreisler, K Dujardin, J Salleron, A Delval, S Blond, L Defebvre, A Destée, P Krystkowiak.   

Abstract

The purpose of this paper is to describe the effect of 5 years of subthalamic nucleus deep brain stimulation (STN DBS) on levodopa-induced complications, both in everyday life and during an acute challenge with levodopa. Thirty three patients were evaluated during an acute levodopa challenge before surgery and then 1 and 5 years afterwards (both off stim and on stim), using the UPDRS III scale and the CAPSIT-PD scales for dystonia and peak-dose dyskinesia. The UPDRS IV scale was used to assess motor complications in everyday life. The levodopa daily dose and DBS parameters were also recorded. Levodopa-induced complications in everyday life (UPDRS IV) and during an acute levodopa challenge had improved markedly after 1 year (both on and off stim) and still further at 5 years. Peak-dose dyskinesia decreased between the 1- and 5-year measurements. STN DBS decreases levodopa-induced motor complications over the long term. This phenomenon may be explained by (a) overall stabilization of the basal ganglia network and (b) striatal synaptic changes. Our results suggest that DBS leads to both qualitative and quantitative modulations in the corticostriatal loops.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19536584     DOI: 10.1007/s00415-009-5195-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  30 in total

1.  Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson's disease.

Authors:  V Fraix; P Pollak; N Van Blercom; J Xie; P Krack; A Koudsie; A L Benabid
Journal:  Neurology       Date:  2000-12-26       Impact factor: 9.910

Review 2.  Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD).

Authors:  G L Defer; H Widner; R M Marié; P Rémy; M Levivier
Journal:  Mov Disord       Date:  1999-07       Impact factor: 10.338

3.  Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study.

Authors:  A Schrag; N Quinn
Journal:  Brain       Date:  2000-11       Impact factor: 13.501

Review 4.  Network-level neuroplasticity in cortico-basal ganglia pathways.

Authors:  Ann M Graybiel
Journal:  Parkinsonism Relat Disord       Date:  2004-07       Impact factor: 4.891

5.  Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up.

Authors:  W M M Schüpbach; N Chastan; M L Welter; J L Houeto; V Mesnage; A M Bonnet; V Czernecki; D Maltête; A Hartmann; L Mallet; B Pidoux; D Dormont; S Navarro; P Cornu; A Mallet; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

6.  Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible?

Authors:  B P Bejjani; I Arnulf; S Demeret; P Damier; A M Bonnet; J L Houeto; Y Agid
Journal:  Ann Neurol       Date:  2000-05       Impact factor: 10.422

7.  Stimulation of subthalamic fibre tracts reduces dyskinesias in STN-DBS.

Authors:  J Herzog; M Pinsker; M Wasner; F Steigerwald; S Wailke; G Deuschl; J Volkmann
Journal:  Mov Disord       Date:  2007-04-15       Impact factor: 10.338

8.  Clinical predictive factors of subthalamic stimulation in Parkinson's disease.

Authors:  M L Welter; J L Houeto; S Tezenas du Montcel; V Mesnage; A M Bonnet; B Pillon; I Arnulf; B Pidoux; D Dormont; P Cornu; Y Agid
Journal:  Brain       Date:  2002-03       Impact factor: 13.501

9.  Exhaustive, one-year follow-up of subthalamic nucleus deep brain stimulation in a large, single-center cohort of parkinsonian patients.

Authors:  Melissa Tir; David Devos; Serge Blond; Gustavo Touzet; Nicolas Reyns; Alain Duhamel; Olivier Cottencin; Kathy Dujardin; François Cassim; Alain Destée; Luc Defebvre; Pierre Krystkowiak
Journal:  Neurosurgery       Date:  2007-08       Impact factor: 4.654

Review 10.  Functional imaging in Parkinson's disease: activation studies with PET, fMRI and SPECT.

Authors:  Andres O Ceballos-Baumann
Journal:  J Neurol       Date:  2003-02       Impact factor: 4.849

View more
  17 in total

Review 1.  Parkinson's disease and 2009: recent advances.

Authors:  David P Breen; Roger A Barker
Journal:  J Neurol       Date:  2010-04-08       Impact factor: 4.849

2.  Targeting the brain: considerations in 332 consecutive patients treated by deep brain stimulation (DBS) for severe neurological diseases.

Authors:  Angelo Franzini; Roberto Cordella; Giuseppe Messina; Carlo Efisio Marras; Luigi Michele Romito; Alberto Albanese; Michele Rizzi; Nardo Nardocci; Giovanna Zorzi; Edvin Zekaj; Flavio Villani; Massimo Leone; Orsola Gambini; Giovanni Broggi
Journal:  Neurol Sci       Date:  2012-01-24       Impact factor: 3.307

Review 3.  Axial disability and deep brain stimulation in patients with Parkinson disease.

Authors:  Alfonso Fasano; Camila C Aquino; Joachim K Krauss; Christopher R Honey; Bastiaan R Bloem
Journal:  Nat Rev Neurol       Date:  2015-01-13       Impact factor: 42.937

4.  Longitudinal medication profile and cost savings in Parkinson's disease patients after bilateral subthalamic nucleus deep brain stimulation.

Authors:  Jing Han Ng; Angela An Qi See; Zheyu Xu; Nicolas Kon Kam King
Journal:  J Neurol       Date:  2020-05-04       Impact factor: 4.849

Review 5.  Dopaminergic therapy and subthalamic stimulation in Parkinson's disease: a review of 5-year reports.

Authors:  Luigi M Romito; Alberto Albanese
Journal:  J Neurol       Date:  2010-11       Impact factor: 4.849

Review 6.  Contribution of serotonergic transmission to the motor and cognitive effects of high-frequency stimulation of the subthalamic nucleus or levodopa in Parkinson's disease.

Authors:  Sylvia Navailles; Philippe De Deurwaerdère
Journal:  Mol Neurobiol       Date:  2012-01-06       Impact factor: 5.590

7.  Deep brain stimulation for movement disorders. Considerations on 276 consecutive patients.

Authors:  Angelo Franzini; Roberto Cordella; Giuseppe Messina; Carlo Efisio Marras; Luigi Michele Romito; Francesco Carella; Alberto Albanese; Michele Rizzi; Nardo Nardocci; Giovanna Zorzi; Edvin Zekay; Giovanni Broggi
Journal:  J Neural Transm (Vienna)       Date:  2011-05-20       Impact factor: 3.575

Review 8.  Preoperative Levodopa Response and Deep Brain Stimulation Effects on Motor Outcomes in Parkinson's Disease: A Systematic Review.

Authors:  Zhengyu Lin; Chencheng Zhang; Dianyou Li; Bomin Sun
Journal:  Mov Disord Clin Pract       Date:  2021-12-09

Review 9.  Subthalamic deep brain stimulation and levodopa in Parkinson's disease: a meta-analysis of combined effects.

Authors:  Joaquin A Vizcarra; Miguel Situ-Kcomt; Carlo Alberto Artusi; Andrew P Duker; Leonardo Lopiano; Michael S Okun; Alberto J Espay; Aristide Merola
Journal:  J Neurol       Date:  2018-06-16       Impact factor: 4.849

10.  [Deep brain stimulation for Parkinson's disease: timing and patient selection].

Authors:  R Erasmi; G Deuschl; K Witt
Journal:  Nervenarzt       Date:  2014-02       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.